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Abstract
Doctors often rely on their past experience in order to diagnose patients. For a doctor with enough
experience, almost every patient would have similarities to key cases seen in the past, and each new patient
could be viewed as a mixture of these key past cases. Because doctors often tend to reason this way, an
efficient computationally aided diagnostic tool that thinks in the same way might be helpful in locating key past
cases of interest that could assist with diagnosis. This article develops a novel mathematical model to mimic
the type of logical thinking that physicians use when considering past cases. The proposed model can also
provide physicians with explanations that would be similar to the way they would naturally reason about cases.
The proposed method is designed to yield predictive accuracy, computational efficiency, and insight into medical
data; the key element is the insight into medical data – in some sense we are automating a complicated process
that physicians might perform manually. We finally implemented the result of this work on two publicly available
healthcare datasets, for (1) heart disease prediction and (2) breast cancer prediction.
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1Bayesian Patchworks: An Approach to
Case-Based Reasoning
1 INTRODUCTION & LITERATURE REVIEW
Doctors often rely on their past experience in order to diagnose patients, often considering similar cases from
the past to diagnose a new case. A radiologist might consider how similar a medical image is to an exemplar
from a medical reference book, or an image from one of their own past cases. An infectious disease specialist
might consider how similar someone’s symptoms are from past patients in order to diagnose an illness. For a
doctor with enough experience, almost every patient would have similarities to key cases seen in the past, and
each new patient could be viewed as a mixture (a patchwork) of these key past cases. Because doctors often
tend to reason this way, a computationally aided diagnostic tool that thinks in the same way might be helpful
in locating key past cases of interest that could assist with diagnosis.
More generally, beyond medical decisions, it is well known that various types of exemplar-based reasoning
and prototyping are fundamental to the way humans make tactical decisions [Carroll, 1980, Cohen et al., 1996,
Klein, 1989, Newell and Simon, 1972]. Humans also tend to think of categories as being represented by a specific
member of that category, which is the center of the subfield of cognitive science called prototype theory [Rosch,
1973]. It has been shown that often, user confidence in a solution is increased when an example case is displayed
rather than the logic of the decision rule alone [Cunningham et al., 2003]. The fact that medical students and
MBAs are taught through case-based teaching methods is not a coincidence, it is because this type of thinking
is how our minds work. In recognition-primed decision making [Klein, 1989] for fire-fighters, students are taught
to consider past cases in order to make informed decisions. By using previous experience in form of cases
to understand and solve new problems, case-based reasoning has been reported as a suitable and successful
technique for medical knowledge-based systems and medical decision making (see for example Schmidt et al.
[2001], Dussart et al. [2008] and the discussion about the medical domain).
Case-Based Reasoning (CBR) (see Aamodt and Plaza [1994], Biswas et al. [2014], Slade [1991],
Irissappane and Zhang [2015]) is a subfield of artificial intelligence dedicated to automated exemplar-
based decisions. CBR has been used in real-world applications for many years (e.g., Anaissi et al. [2015],
Bichindaritz and Marling [2006], Janssen et al. [2015], Li and Sun [2008]), including many medical applications
Begum et al. [2011, 2009]. Researchers have used case-based reasoning for treatments of patients with anxiety
disorders [Janssen et al., 2015], while others have used it for elder care and health assessments [Hu et al., 2014],
analyzing gene expression data to study acute lymphoblastic leukemia (ALL) [Anaissi et al., 2015], and to
study patient registration on renal transplant waiting lists [Campillo-Gimenez et al., 2013]. Many case-based
reasoning systems use some form of nearest neighbor method [Cover and Hart, 1967] (also see Anaissi et al.
[2015], Cover and Hart [1967], Song et al. [2013]). Several works provide in-depth discussions of the issues and
challenges of applying case-based reasoning in medical domains [Bichindaritz and Marling, 2006, Begum et al.,
2011, 2009].
2Our approach is different than typical case-based reasoning approaches in that each new case is modeled
as a mixture of different parts of past cases, where the past cases vote on the features and label of the new
case. In essence, each patient is modeled as if it were a patchwork of parts of past cases. This approach avoids
fixing a single similarity measure as in nearest neighbor approaches; we want to compare patients only on
relevant subsets of features. For instance, hip-injury patients should be compared only on the similarity of
their hip injuries (and age and related characteristics), and heart patients should be compared only on aspects
related to heart health. The definition of a patient’s neighbors should depend on how they are being compared,
and different comparisons should be made based on different subsets of features. Our method performs joint
inference on the selection of past cases that are influential to each new case, the subset of features of the
past cases that are relevant to the new case, and how strong the influences of the past cases are on the new
case. Because we use Bayesian hierarchical modeling, the hierarchy allows us to borrow information across
cases about which features are important for new cases. The hierarchical Bayesian setting helps to quantify
uncertainty, and yields reasonable estimates of the (meaningful) parameter posteriors, and avoids over-fitting.
We hope that by providing doctors with the logic they would have considered anyway, had they been able
to do lengthy querying of the database for each case, doctors will be more likely to trust the model and make
personalized decisions that are both evidence-based and experience-based. This method can help train doctors
as well, by showing them how the key elements of past cases are relevant. It should be pointed out that our
model can be applied in other application settings where interpretability of the model is of some importance.
Examples are criminal justice, and energy reliability. We should point out that for policy-based decisions that
rely on subpopulations, our model may not be the right approach.
In Section 2, the structure of the main model and the developed hierarchical framework are presented, along
with a useful extension. In Section 3 we show the result of our models on two healthcare datasets which are
publicly available. We also compare our model with some other important machine learning algorithms in
Section 3. Several appendices include details of the inference procedure.
2 STRUCTURE OF BAYESIAN PATCHWORKS
Each patient (“case”) is represented by a vector of features, including history of treatments, genetic makeup,
environmental factors, and lifestyle. In this model, each patient is comprised of important pieces of related
individuals. These special individuals, called neighbors, belong to a large historical set of past cases called the
parent set. Stated in terms of the generative structure of the model, each patient is generated from its neighbors,
where the neighbors give the new patient their influential features. The neighbors also vote to determine the
label for the new case. Figure 1 illustrates this, where each feature of a new patient’s medical state is considered
with respect to other patients (parents) that are similar in that feature.
Thinking in reverse (starting from the patient, rather than its generative process), this form of mathematical
modeling naturally leads to answers to the following questions: For a new patient with unique characteris-
tics/features, what are important similar past cases? How close are these past cases to the current patient and
what are the special factors that make this past case resemble the current case? How can this similarity help with
inference – can we infer the patient’s health condition and possible treatments using the influential neighbors?
3Fig. 1: Illustration of the Bayesian Patchworks model. Each feature of a new case (the new case is represented
by the person in the center) is considered with respect to other cases with similar features (people around
the outside). When we consider an aspect of the new patient’s health (e.g., his skin), we would look at other
patients who are similar in that aspect (for instance the patient on the lower right who has a similar case of
mild dermatitis).
The answers to these questions are learned (inferred) from the data with our hierarchical model. We introduce
the main important variables below. After that we will introduce the full-blown generative model.
Each individual has P features (e.g., age, race, gender, treatment or diagnosis-related features, drugs), and
we denote the jth feature of the ith observation as xij . The jth feature can take any of its Vj possible discrete
outcomes. The set of feature values associated with the ith individual are denoted by vector xi. Each individual
is associated with one of theM possible health classes/outcomes, which we denote for the ith individual by yi.
The whole dataset is then denoted by (X,Y). The main parameters of the model are as follows:
zib: This is an indicator variable denoting whether patient b from the parent set is in the neighbor set of
individual i (we say “b is a neighbor of i”). A patient and its neighbors share at least some important common
properties. The neighbors for several cases can be the same. We have zib ∈ {0, 1}, i ∈ {1, · · · , N}, and b ∈
{1, · · · , S} and N is the number of current cases, S is the number of parents (past cases).
wibj : This binary parameter (where i ∈ {1, · · · , N}; b ∈ {1, · · · , S}; j ∈ {1, · · · , P}) shows whether feature j
of neighbor b is important to individual i, and thus shows whether two cases (a new case and a case from the
pool of past cases in the parent set) are connected to each other.
gij(v): This determines the probability that feature j of patient i takes value v. Specifically, it determines
4how likely outcome v will be copied from the neighbors. The vector gij for the vth outcome of feature j
(j ∈ {1, · · · , Vj}) is calculated as follows:
gij(v) = λ0 + λ
∑
b
1[zib = 1 and wibj = 1 and xbj = v]. (1)
Based on this definition, we have a boost in the score gij(v) for the vth outcome of feature j for any neighbor b
who has outcome v for feature j. Here λ0 is the baseline rate of seeing outcome v, and λ determines how much
influence each neighbor b has.
hi(m): This determines how much the neighbors of individual i influence it to choose the mth class label
(m ∈ {1, · · · ,M}). This variable is defined as
hi(m) = µ0 + µm
∑
b
1[zib = 1 and yb = m]. (2)
Here, µ0 and µm(m ∈ 1, ...,M) are the hyperparameters that together reflect how neighbors can affect the
generation of a label. In this paper we assumed that µm = µ ∀m ∈ 1, ...,M . If
µ0
µ
is very large, then neighbors
are not important in determining the class of each individual. We will discuss extensions of this model later in
the paper.
Consider the generation process for individual i. After the values z = [zij ] and w = [wibj ] are generated
for j ∈ {1, ..., J} and b ∈ {1, ..., S}, we know i’s neighbors and their influences. From there, gij(:) generates
vector (φij(:)) and then finally φij(:) generates the value of the jth feature of individual i (i.e., xij ∼ Cat(φij(:
)), ∀j ∈ {1, ..., J}). Also from z, we know hi(:) that generates the outcome for individual i (i.e., yi ∼ Cat(θi)).
As an example, we consider a patient i. All of the past patients with common properties are neighbors, so that
zib = 1. The first neighbor has a circulatory system condition that is similar to patient i. The second neighbor
has a hip injury similar to patient i, and so on. Each of these medical conditions of the neighbors provide some
information about patient i’s features and labels. For the information from neighbor b that definitely informs
feature j for patient i, we would have wibj = 1, and the probability that patient i would have the same value v
of the feature as the neighbor would be large, meaning gij would be large for value v. If neighbor b influences
i’s class label, then hi would be large for neighbor b’s class label. This way, we can consider a patient as a
patchwork of past patients that are similar to the present patient. The neighbors’ important characteristics (the
hip injury, the circulatory condition, etc.) all contribute to the features and outcomes for the present patient.
An understanding of these similar past patients serves as a point of reference for how to care for the present
patient.
2.1 Full Hierarchical Bayesian Patchworks Model (Model I)
The variables of the hierarchical model (herein denoted BPatch) are as follows:
zib: Here zib (i ∈ {1, · · · , N}, b ∈ {1, · · · , S}) follows a Bernoulli distribution with parameters α, where
hyperparameter α denotes how many neighbors each individual tends to have on average. This parameter
controls how many parents generate each individual. Note that if α is chosen to be large, then the model may
overfit by choosing many cases from the parent set as neighbors.
5qj : This parameter determines the general importance of feature j ranging from 0 to 1,
qj ∼ Beta(γ, σ1).
The hyperparameters γ and σ1 control the number of features used for generating the new observations and
their class labels.
q˜bj : This parameter determines the importance of feature j to parent b. Its values follow a Beta distribution
centered around mean qj , that is, q˜bj ∼ Beta(σ2 qj/(1 − qj), σ2). (To see that the mean is qj note that the mean
of the Beta(α, β) distribution is 1/(1 + β/α).) Here, σ2 is another hyperparameter that governs the sparsity of
the distribution q˜bj . The intuition behind this parameter is that if it is set to a value that makes the variance
of the Beta(σ2 qj/(1 − qj), σ2) too large, then some neighbors may be very influential for feature j and some
neighbors will not be influential. If it is set to a value that makes the variance too small, then neighbors may all
be approximately equally influential for feature j.
wibj : As explained earlier, this binary parameter shows whether feature j of neighbor b is important to
individual i. This is determined via:
wibj ∼ Bernoulli(q˜bj).
This allows for individual level effects on neighbor b’s influence for feature j.
φij : The distribution of values for feature j for individual i comes directly from the gij ’s (as given in Eq. (1)),
that is
φij ∼ Dirichlet(gij(:)),
which means φij(v) ≥ 0, ∀(i, j, v) and
∑
v
φij(v) = 1. So, φij is the distribution of feature values for the jth
feature of the ith individual.
xij : The jth feature of the ith individual, xij , is generated from a categorical distribution with parameter vector
φij(:). Therefore, the probability that xij takes its vth outcome becomes φij(v).
Now that we have generated the observations, we need only to generate the class labels.
θi(m): The distribution of class outcomes for individual i will be determined by hi defined in Eq. (2) through
θi(:) ∼ Dirichlet(hi(:)).
This way, θi(m) ≥ 0 for all (i,m) and
∑
m
θi(m) = 1 for all i.
yi: The distribution of class outcomes for individual i is generated from a categorical distributionwith parameter
vector θi. To use our model for classification, the class with the highest probability θi(m) can be used as the
predicted class.
According to this model, neighbors of an individual i determine both its feature values xi and its outcome
yi. The hyperparameters of our model are (α, γ, σ1, σ2, λ0, λ, µ0, µ). The graphical model is illustrated in Fig. 2.
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Fig. 2: Plate diagram (directed acyclic graph) for an influential neighbor model (Model I). Circles indicate
stochastic nodes; squares indicate fixed nodes (hyperparameters); directed edges (arrows) indicate the direction
of influence. In this structure zib, b = {1, · · · , N} is one of the two key indicator variables denoting if neighbor
b from the past cases is an influential neighbor of individual i. The 2nd key variable is wibj , which shows the
importance of feature j of neighbor b on affecting individual i. The outcomes of this generative model are the
xij ’s and yi’s.
The full model given all hyperparameters is summarized below:
zib ∼ Bernoulli(α) ∀(i, b),
qj ∼ Beta(γ, σ1) ∀j, q˜bj ∼ Beta(σ2 qj/(1− qj), σ2) ∀(b, j), wibj ∼ Bernoulli(q˜bj) ∀(i, b, j),
gij(v) = λ0 + λ
∑
b
1[zib = 1 and wibj = 1 and xbj = v],
φij(:) ∼ Dirichlet(gij(:)) ∀(i, j), xij ∼ Cat(φij(:)) ∀(i, j),
hi(m) = µ0 + µ
∑
b
1[zib = 1 and yb = m],
θi ∼ Dirichlet(hi(:)) ∀i, yi ∼ Cat(θi) ∀i.
To summarize, the zib determine who the relevant neighbors are for i, the next three lines determine how
the features are generated from the values of the neighbors, and the two lines after that determine how the
labels are generated. Inference for the model is discussed in Appendix A.
2.1.1 Continuous Features
Model I can be edited to handle continuous features in several ways. One option is to use a bandwidth or a
binary distance function that determines whether two feature values in the continuous domain are close:
gij(v) = λ0 + λ
∑
b
1[zib = 1 and wibj = 1 and Ij(xbj , v)],
7where Ij is a binary similarity measure/kernel for the jth feature. A simple example of such measure is a binary
kernel with a bandwidth rj as follows:
Ij(xbj , v) =∝


1, if |xbj − v| ≤ rj
0, otherwise.
From there, φij and xij values could be generated from a normal distribution or another continuous
distribution.
2.1.2 More Complicated Outcome Relationships
Once the features xij are generated, if desired one could replace the outcome model with any other standard
generative modeling procedure (e.g., linear regression model or logistic regression). We chose a simple voting
model for the outcome, where each neighbor casts one vote for their own outcome.
2.1.3 Handling Missing Points
Handling missing data is not the focus of the paper, one may handle it in the usual way, for instance, by
performing any method for imputation. Other than the above method, our model can be updates as follows to
deal with missing points: for each dimension of features, we can add an artificial output representing missing
value. For example for feature j with Vj possible discrete outcomes, we add an artificial outcome Vj + 1 and
replace all missing values in that direction with it.
2.2 Comparison with closely related work
Now that we have introduced the full model, we can give a more technical description of how the models
presented above differ from ordinary nearest neighbor techniques (k-nearest neighbor – KNN) as well as the
Bayesian Case Model (BCM) [Kim et al., 2014], and Latent Dirichlet Allocation (LDA).
Nearest Neighbors: In KNN, adaptive nearest neighbors, or nearest prototype models, there is a single fixed
distance metric used for comparing a current observation to past observations. Here, the choice of distance
metric depends on the observation. This allows, for instance, a patient with a heart condition and sports injury
to be neighbors of patients with a similar heart condition (regardless of sports injury), and patients with a
sports injury (regardless of heart condition). Our method can be viewed as a version of nearest neighbors that
is much more flexible, in terms of how many neighbors are used, the distance metric between neighbors, and
the completeness of the characterization of the new patient by the neighbors.
Bayesian Case Model: First, BCM is unsupervised, while BPatch is supervised. More importantly, BPatch
includes individual level effects for influences of parents, whereas BCM uses prototypes instead. BCM limits new
cases to be compared with only certain learned past cases (the prototypes). An easy way to see this is that
BPatch has variables wibj for each unit, controlling whether feature j of neighbor b is important for observation
i. In BCM, the analogous parameter wsj only determines whether feature j is important for cluster s, and
there is no individual level effect. As a result, the whole model for BPatch is different: in order to determine
the distribution of values for any feature j (which is φij ), BPatch needs to consider how many parents are
going to generate it (controlled by zib). In contrast, BCM’s φs values depend only on the cluster s. For BCM,
8zij takes on values that are single cluster indices (“Which cluster will generate feature j for individual i?”),
whereas for BPatch, zib determines which parents generate individual i (“Which parents will be allowed to
generate individual i’s features?”). As a result, BPatch’s generation of features is a result of a vote among
parents, whereas BCM’s generation of features is a result of a single prototype sharing its feature with the new
observation. By considering individual level effects, generated for each individual as a patchwork of its parents,
BPatch is conceptually different than BCM, which is cluster-based. BPatch is more similar to nearest neighbors
than prototype- or cluster-based modeling like BCM.
Note that there are papers dealing with supervised prototype classification other than BCM (e.g.,
Bien and Tibshirani [2011]), though not using the important parts of each case like BCM and BPatch; this is
problematic, and causes these algorithms to choose a huge number of prototypes in practice. It also limits us
to compare with a single nearest prototype even if our current observation is clearly a mixture of different past
situations.
Latent Dirichlet Allocation: LDA has a strong (and false) assumption that each feature value is generated
independently. BPatch and BCM do not have this assumption, and the generation of features is correlated
(either through clusters or parents). BCM and BPatch are more complicated and more realistic models, leading
to better performance. This was discussed via experiments by Kim et al. [Kim et al., 2014].
2.3 Model II
When generating feature values or outcomes, the previous BPatch model (Model I) counts each vote from a
neighbor equally, whereas in Model II, the votes are weighted by the degree of influence of the neighbor. For
instance, if one neighbor is influential for several features of the current patient, then it should potentially have
a stronger vote than other neighbors in determining the feature values and outcomes. The degree of influence
of a neighbor depends on the influences of its individual features. We denote κib, 0 ≤ κib ≤ P , as the degree of
influence between case i and parent b, which is
κib = zib
∑
j
wibj .
The higher κib is for parent b, the stronger its influence is on individual i. This is different from Model I where
the influence of parent b on individual iwas determined through a binary indicator zib. In Model II, the amount
that each influential neighbor can potentially affect feature j of individual i is defined as
gnewij (v) = λ0 + λ
∑
b
κib 1{wibj = 1 andxbj = v}, (3)
and similarly the vote for the outcome can be weighted as
hnewi (m) = µ0 + µ
∑
b
κib1{yb = m}. (4)
Based on this model, not only how many neighbors vote for a feature matters but also how strongly they vote
matters too. The rest of the parameters are the same as the model given in Section 2. In this model, the degree
of influence directly depends on how similar each pair of individuals are. Based on this definition, if zib = 0,
then κib = 0, and if zib 6= 0 then κib equals
∑
j
wibj . The directed acyclic graph of this model is given in Fig. 3.
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Fig. 3: Plate diagram for Model II. Circles indicate stochastic nodes; squares indicate fixed nodes; directed edges
(arrows) indicate parent–child relations.
The variable κ in this model is not a parameter to be estimated as it can be calculated from w and z.
However the structure of the posterior and conditionals are different from the original model in the sense that
yi now depends also on all wi::.
The posterior for Model II is derived in Appendix B.
We also propose a possible third model (Model III) in Appendix C, where the relationship between parent b
and individual i can have a degree/weight between 0 and 1 following a Beta distribution. This is different from
both Models I and II where zib was a binary variable. Model III did not tend to perform well, and we chose
to omit it in our experiments. It is possible that improvements to the model might lead to better performance,
though we leave that for future work.
2.4 Health Outcome/Label Prediction
Let us assume that a new patient r with a feature set xr is available, for which we may or may not have the
health label yr . We can use our model to make three types of predictions for this new individual as follows:
(I) For a known xr and unknown yr, what are the set of influential neighbors zrb, for b ∈ {1, · · · , S}, and
their influences wrbj , for j ∈ {1, · · · , Vj}, b ∈ {1, · · · , S}?
(II) For the same setting as (I) above, what is the estimated probability of being at each health outcome, and
what is the predicted outcome yˆr?
(III) For a set of known (xr, yr), what are the set of influential neighbors zrb, b ∈ {1, · · · , S} and their
influences wibj , for j ∈ {1, · · · , Vj}, b ∈ {1, · · · , S}?
The answers to prediction problems (I) and (II) can be obtained in a completely unsupervised way. That is, they
can be answered having removed the right part of the model in Fig. 2 that generates labels Y. In other words,
we do not need the outcomes of the parent set for inference in the unsupervised case.
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3 NUMERICAL EXPERIMENTS: APPLICATIONS TO HEALTHCARE ANALYTICS
We applied our models to two healthcare problems, heart disease and breast cancer predictions. Then, in Section
3.5, we applied our models to a larger data set with more features.
Heart Disease Diagnosis: The Cleveland database (Cleveland Clinic Foundation), obtained via
[Bache and Lichman, 2013], reports the presence of heart disease in 303 patients, 274 of which had no missing
information, each labeled with whether they had heart disease, and features are described in Table 1.
TABLE 1: Description of the heart disease data used in this study
# Feature Name Number of Possible Outcomes Description
1 Age 3 (0,45),[45,55),[55,100)
2 Gender 2 Male, Female
3 Chest Pain Type 2 1 or 2, 3, 4
4 Trestbps (blood pressure) 3 (0,120], (120,140],(140, 300)
5 Serum Cholestrol (Chol) 3 (0,240], (240,260], (260,400)
6 Fasting Blood Sugar 2 0, >0
7 Resting Electrographic Results (Restecg) 2 0, >0
8 Maximum Heart Rate Achieved (Thalach) 3 (0,50],(50,65],(65,202)
9 Exercise induced Angina (Exang) 2 0, >0
10 Oldpeak 2 (0,0.5], (.5,6.2)
11 Slope of the peak 2 1, 2 or 3
12 Number of major vessels colored by fluoroscopy (Ca) 2 0, 1 or 2 or 3
13 Thal 2 3, >3
Label Heart Disease 2 Presence, Absence
Breast Cancer Recurrence Prediction: We used a dataset provided by the Oncology Institute, University
Medical Centre, Ljubljana, Yugoslavia [Bache and Lichman, 2013]. The attributes are described in Table 2, and
each observation was labeled as to whether it led to recurrence of breast cancer. After removing patients with
missing values, we randomly selected a balanced set of 162 patients (81 from each class) for our analysis.
3.1 Prediction Results
Both supervised and unsupervised versions of BPatch perform about equally well in predicting patients with
cancer and heart disease. This indicates that learning a good set of neighbors is useful not only for characterizing
the current patient’s features, but also for predicting their label. Let us show this.
The hyperparameters were chosen as follows: α = 0.5, σ1 = 5, γ1 = 0.5, γ2 = 0.5, µ0 = 0.001, µ = 1,
λ0 = 0.001, λ = 2. The number of parents was initially chosen to be 80 (S = 80) for both datasets. Parents
were randomly selected from the training sets in each fold. In Section 3.3, we discuss the sensitivity of the
prediction results with respect to all hyperparameters and discussed why these parameters are interpretable in
that they can control both the structure of the model and its accuracy/prediction power. Prediction evaluation
was performed in two ways, unsupervised and supervised. For the unsupervised analysis, the model structure
was trained without using the outcome of any of the patients in the training set and only the vector of patient
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TABLE 2: Description of the breast cancer data used in this study
# Feature Name Number of Outcomes Description
1 Age 3 (0,50),[50,59),[60,100)
2 Menopause 3 <40, ≥40, premeno
3 Tumor-size 4 [0,19], [20,29],[30,39], [40,59]
4 Inv-nodes (blood pressure) 2 (0,2], >2
5 Node-Caps 2 yes, no
6 Deg-malig 3 1,2,3
7 Breast 2 left, right
8 Breast-Quad 4 left-up, left-low, right-up, or right-low, central
9 Irradiant 2 yes, no
Label class distribution 2 no-recurrence-events, recurrence-events
attributes was used to infer model parameters. In other words, the neighbors and their influences were found
solely from the feature values (see Section 2.4). Note that while the training process itself is unsupervised, we
did use the trained parameters along with the labels of training points in order to make predictions for the
cases in the test set. The training set determines how we should combine the neighbors’ labels to produce a
label for the current case. In the supervised case, we used the information on the actual health outcomes of the
patients in the training set both to train the model and to make predictions for the new cases. For both cases,
we performed 5-fold cross-validation; here we divided our data into five folds, each with the same number of
parents, trained our models on four folds and tested on the fifth.1 We performed all experiments for both data
sets using Model I and Model II. After training, we used the posterior predictive distribution of θ to estimate
the probability of having heart disease and breast cancer (as a recurrent event) for all patients in the test set.
Using the estimated probability θi for patient i as a classification input (where 0.5 is the threshold), we then
calculated the classification accuracy, sensitivity, specificity, precision, recall, and F-measure (see Tables 3 and
4). We reported these measures for each fold and followed by the mean and standard devision over folds.
We can observe from the results in Tables 3-4 that both supervised and unsupervised version of Model I
and Model II perform well in terms of classifying patients with heart disease and breast cancer conditions.
The supervised version performs slightly better in both data sets, which is not surprising because it uses more
information (the labels y of past cases) for estimation of parameters. In the unsupervised case, recall that the
labels of past cases were not used to train the model parameters, however, they were used to make predictions
from the trained parameters. That is, without using the health outcomes of past cases, our models inferred which
neighbors to consider for predicting health outcomes simply by looking at neighbors with similar patterns in feature
values.
1. The individuals in the parent list were chosen uniformly at random in each fold. We repeated our experiments with fixed sets
of parents over all folds. The results were similar to models trained with different parents in each fold (omitted here).
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TABLE 3: Prediction results for the heart disease dataset using Models I and Model II
Supervised
Measure Accuracy Sensitivity Specificity Precision Recall
Fold Model I Model II Model I Model II Model I Model II Model I Model II Model I Model II
1 74.55 81.82 73.33 73.33 76.00 92.00 78.57 91.67 73.33 73.33%
2 78.18 76.36 80.00 80.00 76.00 72.00 80.00 77.42 80.00 80.00%
3 78.18 78.18 69.23 73.08 86.21 82.76 81.82 79.17 69.23 73.08%
4 92.73 92.73 92.31 92.31 93.10 93.10 92.31 92.31 92.31 92.31%
5 90.74 88.89 96.00 100.00 86.21 79.31 85.71 80.65 96.00 100.00%
Mean 82.88 83.60 82.17 83.74 83.50 83.83 83.68 84.24 82.17 83.74%
SD 8.25 7.01 11.66 11.98 7.41 8.86 5.52 7.17 11.66 11.98%
Unsupervised
Measure Accuracy Sensitivity Specificity Precision Recall
Fold Model I Model II Model I Model II Model I Model II Model I Model II Model I Model II
1 72.73 72.73 73.33 73.33% 72.00 72.00 75.86 75.86 73.33 73.33%
2 76.36 74.55 76.67 76.67% 76.00 72.00 79.31 76.67 76.67 76.67%
3 80.00 80.00 73.08 76.92% 86.21 82.76 82.61 80.00 73.08 76.92%
4 89.09 94.55 84.62 100.00 93.10 89.66 91.67 89.66 84.62 100.00%
5 87.04 87.04 92.00 92.00% 82.76 82.76 82.14 82.14 92.00 92.00%
Mean 81.04 81.77 79.94 83.78 82.01 79.83 82.32 80.87 79.94 83.78%
SD 6.94 9.06 8.20 11.59 8.33 7.69 5.88 5.53 8.20 11.59%
Model II tended to have better performance than Model I in both data sets as it gives more weights to
neighbors with more similar features. As discussed before, Model II is computationally more expensive than
Model I and thus takes longer to converge. See Section 3.5 for the discussion on CPU analysis of two models.
BPatch produces probabilistic estimates for each class, unless other nearest neighbor models (and unlike
BCM which is unsupervised). We plotted the estimated probability of having heart disease and a recurrent
breast cancer event for the patients in the test sets in Figure 4. This figure shows that the probability of the
health condition of interest tends to be higher for patients who actually have that condition.
3.2 Discussion on Interpretability
Interpretability is known to be a major concern in machine learning for high-stakes decisions, but it is context-
dependent, subjective, and hard to quantify. In what follows, we discuss three aspects of interpretability: the
view of each patient through the lens of the neighbors, discussed in Section 3.2.1, and feature importance in
Section 3.2.2. We also further provide an interpretability comparison in Section 3.4 to BCM, KNN, and decision
trees.
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TABLE 4: Prediction results for the breast cancer dataset using Models I and II
Supervised
Measure Accuracy Sensitivity Specificity Precision Recall
Fold Model I Model II Model I Model II Model I Model II Model I Model II Model I Model II
1 68.75 71.88 92.86 92.86 50.00 55.56 59.09 61.90 92.86 92.86%
2 90.91 87.88 100.00 100.00 80.00 73.33 85.71 81.82 100.00 100.00%
3 62.50 71.88 57.14 71.43 66.67 72.22 57.14 66.67 57.14 71.43%
4 84.38 81.25 87.50 81.25 81.25 81.25 82.35 81.25 87.50 81.25%
5 84.85 81.82 94.74 89.47 71.43 71.43 81.82 80.95 94.74 89.47%
Mean 78.28 78.94 86.45 87.00 69.87 70.76 73.22 74.52 86.45 87.00%
SD 12.04 6.95 16.98 11.01 12.65 9.36 13.89 9.50 16.98 11.01%
Unsupervised
Measure Accuracy Sensitivity Specificity Precision Recall
Fold Model I Model II Model I Model II Model I Model II Model I Model II Model I Model II
1 76.36 71.88 76.67 92.86 76.00 55.56 79.31 61.90 76.67 92.86%
2 76.36 87.88 76.67 100.00 76.00 73.33 79.31 81.82 76.67 100.00%
3 59.38 65.63 57.14 71.43 61.11 61.11 53.33 58.82 57.14 71.43%
4 89.09 84.38 84.62 87.50 93.10 81.25 91.67 82.35 84.62 87.50%
5 78.79 84.85 89.47 94.74 64.29 71.43 77.27 81.82 89.47 94.74%
Mean 76.00 78.92 76.91 89.30 74.10 68.54 76.18 73.34 76.91 89.30%
SD 10.67 9.64 12.33 10.95 12.58 10.21 13.99 11.90 12.33 10.95%
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Fig. 4: Estimated probability of Heart Disease and Breast Cancer Using Model II - Results are based on the cases
in the 5 test sets; the dashed horizontal line is the 50% threshold. The points on the left side of each plot (dot
circles) are associated with patients with no health condit
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Fig. 5: Example of two patients with breast cancer and 4 similar past cases in the Parents set. Note that the top
four parents are shown only. The feature names are shown inside the bracket above the figure.
3.2.1 Insight About Cases from Bayesian Patchworks
BPatch can potentially pinpoint which past cases are similar to a new case, why certain past patients are similar
to a new case, how similar they are, and how this similarity is quantified. Let us show by few examples.
In Figures 5-8, the top neighbors/parents with the highest κi,b are shown for four sample patients with and
without breast cancer and heart disease. For each sample, the feature values of the parent associated with
important dimensions are shown in bold (i.e., when wibj = 1). It can also be seen that each parent has a unique
combination of features that are important for that parent. The parents that are selected as neighbors tend to
be similar to the patients on the important features for each parent. Consider Sample Patient 1 in Fig. 5 for
instance. It can be seen that its Parents 1-4 have some features identical to those of Sample Patient 1. Patients
with cancer are connected more often to parents with cancer. For example, three out of the selected four parents
have the same health label as Patient 1. Doctors now can look at all selected parents and see why these parents
are selected as the influential neighbors and use the predicted probability of the health condition from the
neighbors to make their medical decision or diagnosis. Doctor can also use these results to investigate similar
past cases in terms of possible treatments in order to make better treatment decisions.
3.2.2 Feature Importance
Bayesian Patchworks has parameters that directly mirror feature importance. These parameters can be used to
compare the importance of each feature for distinguishing individuals from different classes.
In Fig. 9, the posterior predictive distribution of qj for the features used in both data sets are shown for the
unsupervised version of Model II. We can observe from this figure that features such as age and blood pressure
seem to be more important than features like Serum Cholesterol or Resting Electrographic Results for finding
the influential neighbors of each individual. We carried out the same experiments for the breast cancer dataset
and plotted the posterior predictive distribution for qj . Since we could not find any strong scientific resource
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Fig. 6: Example of two patients without breast cancer and four similar past cases in the Parents set.
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Feature Vector =  
[Age, Gender, Chest pain type, blood pressure, Chol, Blood Sugar, Restecg, Thalach, Exang, Oldpeak, Slope of the peak, Ca, Thal] 
Fig. 7: Example of two patients with heart disease and four similar past cases in the Parents set. The feature
names are shown inside the bracket above the figure.
to directly evaluate or approve these findings, we indirectly evaluate them, by comparing to another feature
importance approach: first we used only the top 3 features to train the model; next, we used the next 3 features
(feature ranked 4th, 5th, and 6th); finally the next 3 features (feature ranked 7th, 8th, and 9th) and evaluated the
prediction power of the model and compared with the case of when all features are employed. Results shown
in Fig. 10 indicate that for both datasets, the performance of the top three features alone is similar to when all
features are used. When the less important features are employed, the prediction power of the model degrades.
This result shows that the vector obtained from qj is actually indicative of feature importance. In Subsection
3.4.2, we used estimated feature importance vectors as the feature weight vectors for KNN and saw slightly
improved prediction performance. We repeated this using Model I and other extensions and the results were
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Fig. 8: Example of two patients without heart disease and four similar past cases in the Parents set. The feature
names are shown inside the bracket above the figure.
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Fig. 9: Posterior boxplots for qj associated with the features used in heart disease data set (left) and the features
used in the breast cancer data set (right).
similar.
3.3 Sensitivity analysis for various hyperparameters
Sensitivity analysis in a Bayesian setting can help find out how sensitive a model’s performance is to minor
changes in its hyperparameters. We report below sensitivity analysis to hyperparameters S, α, γ, σ1, and σ2.
3.3.1 Sensitivity analysis for the number of parents (S)
The total number of influential neighbors for each new case is a critical factor in the performance of the model.
While increasing the number of parents S will improve the coverage of parents among the distribution of
patients, it can also make the computational time to train the model longer, and potentially lead to overfitting.
In Figure 11, we show the accuracy of both Model I and Model II under different values of S. As can be seen
for both data sets, the accuracy improves as we increase the number of cases in the parent set for our data.
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Fig. 11: Prediction Accuracy of Model I and Model II under different values of S
3.3.2 Sensitivity analysis for α
As explained earlier, parameter α controls how many parents are an influential neighbor of each individual.
The average number of influential neighbors is S × α. It is expected that large α can improve the performance
of the model, however choosing a very large α may result in selecting all parents as neighbors and possibly
overfitting. Conversely, if α is chosen to be too small, then no parent is selected as the influential neighbor of
each case and the model performs as random guessing. In Figure 12, the accuracy of Model I and Model II
under five different values of α = 0, 0.1, 0.4, 0.7, 1 is given for the two data sets. Under the two extreme cases
of α = 0 and α = 1, the model acts as a random guess with accuracy close to 50%. The best choices for α are at
non-extreme values; ideally α would be cross-validated if computation time permits.
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Fig. 12: Prediction Accuracy of Model I and Model II under different values of α
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Fig. 13: Prediction Accuracy of Model I and Model II under different values of (γ, σ1).
3.3.3 Sensitivity analysis for (γ, σ1)
As explained earlier, qj determines the importance of feature j (ranging between 0-1) and follows a beta
distribution with parameters γ and σ. These hyperparameters will change the shape the distribution for qj and
control the number of features and their importance. To explore different shape types of the beta distribution,
we consider three symmetric cases: (i) a U-shaped distribution with (γ, σ1)=(.5,.5), (ii) a uniform distribution
with (γ, σ1)=(1,1), (iii) a symmetric unimodal distribution with (γ, σ1)=(2,2), and two unimodal cases (iv)
(γ, σ1)=(2,5) and (v) (γ, σ1)=(5,2) with positive and negative skews, respectively. Figure 13 shows the models’
sensitivity to (γ, σ1). In both datasets, the symmetric case of (γ, σ1) = (0.5, 0.5) (the Jeffreys prior for the
Bernoulli and binomial distributions) performs best, but not by very much.
We performed sensitivity analysis for other hyperparameters λ0, λ, µ0, µ, and σ2 and found out that the
model is not very sensitive within the range of reasonable choices.
3.4 Comparison with Existing Models
In this section, we first provide the results of a general comparison between our model and some existing
models. We then more closely compare our model with the most similar models including BCM, KNN, and
decision trees. Our purpose is not to show that our model outperforms these methods in terms of prediction;
all methods perform comparably for our data. We aim instead to show that our model performs well enough,
where interpretability serves as an excellent tie-breaker.
3.4.1 Prediction Accuracy and Comparison with Benchmark Models
The methods we compare with are logistic regression, SVM, BCM, AdaBoost, KNN, random forests, and
decision trees. For each method and each dataset, we performed 5-fold cross-validation and reported the
mean over 5 folds for accuracy, sensitivity, specificity, precision, and recall. The results are summarized in
Table 5, indicating that our methods (Model I and Model II) perform comparably with other machine learning
algorithms.
3.4.2 Comparison with KNN and its extensions
One of the main differences between Bayesian Patchworks and the regular KNN is that unlike KNN that
requires a distance measure that is the same for all instances of data, our model uses an adaptive metric, where
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TABLE 5: Results for comparison between our model (Model II) and selected existing methods on both data
sets.
Model Heart Disease Dataset Breast Cancer Dataset
Learning Type Accuracy Sensitivity Specificity Precision Recall Accuracy Sensitivity Specificity Precision Recall
Proposed Model I 0.83 0.82 0.83 0.84 0.82 0.78 0.86 0.7 0.73 0.86
Proposed Model II 0.84 0.84 0.84 0.84 0.84 0.79 0.87 0.71 0.75 0.87
BCM (S = 4, α = 0.01) 0.80 0.86 0.74 0.78 0.86 0.76 0.93 0.60 0.69 0.93
BCM (S = 4, α = 1) 0.82 0.85 0.80 0.81 0.85 0.75 0.82 0.68 0.72 0.82
BCM (S = 8, α = 0.01) 0.63 0.53 0.75 0.64 0.53 0.68 0.97 0.40 0.62 0.97
BCM (S = 8, α = 1) 0.78 0.80 0.77 0.78 0.80 0.77 0.84 0.71 0.75 0.84
logistic regression 0.82 0.84 0.80 0.81 0.84 0.77 0.89 0.66 0.72 0.89
KNN (30)∗ 0.83 0.85 0.82 0.83 0.85 0.76 0.99 0.54 0.68 0.99
KNN (20) 0.82 0.86 0.79 0.80 0.86 0.76 0.96 0.56 0.69 0.96
KNN (10) 0.81 0.82 0.80 0.81 0.82 0.75 0.99 0.53 0.68 0.99
KNN (5) 0.81 0.82 0.81 0.81 0.82 0.73 0.90 0.57 0.67 0.90
KNN (1) 0.76 0.74 0.78 0.77 0.74 0.68 0.70 0.65 0.66 0.70
Random Forest (5)∗∗ 0.78 0.79 0.77 0.78 0.79 0.78 0.85 0.72 0.75 0.85
Random Forest (10) 0.80 0.81 0.79 0.80 0.81 0.74 0.80 0.68 0.71 0.80
Random Forest (100) 0.83 0.84 0.82 0.83 0.84 0.78 0.87 0.70 0.74 0.87
Decision Tree 0.75 0.77 0.72 0.76 0.77 0.73 0.70 0.75 0.73 0.70
SVM 0.81 0.85 0.76 0.79 0.85 0.79 1.00 0.59 0.71 1.00
boosted DT (100, I)∗∗∗ 0.82 0.80 0.84 0.83 0.80 0.77 0.90 0.65 0.72 0.90
boosted DT (50, I) 0.82 0.81 0.84 0.84 0.81 0.79 0.93 0.65 0.73 0.93
boosted DT (10, I) 0.83 0.81 0.84 0.84 0.81 0.79 0.99 0.60 0.71 0.99
boosted DT (5, I) 0.80 0.81 0.78 0.80 0.81 0.76 0.91 0.62 0.70 0.91
boosted DT (100, II) 0.81 0.85 0.77 0.79 0.85 0.77 0.90 0.65 0.72 0.90
boosted DT (50,II) 0.81 0.85 0.77 0.79 0.85 0.77 0.90 0.65 0.72 0.90
boosted DT (10, II) 0.81 0.85 0.77 0.79 0.85 0.78 0.91 0.66 0.73 0.91
boosted DT (5, II) 0.81 0.85 0.77 0.79 0.85 0.78 0.91 0.65 0.72 0.91
∗∗The numbers in the parentheses are the number of parents. The distance measure for KNN is Hamming. ∗∗∗The
number in the parentheses for random forests is the number of trees. ∗The numbers in the parentheses are the
number of the weak classifiers and the weak learning algorithm type for AdaBoost. The learning for Type 1 is Tree
and for Type II is Discriminant. We used the fitensemble function in Matlab with AdaBoostM1 as the method.
it finds neighbors from parents based on their important features. Also, unlike KNN, BPatch does not force a
fix number of neighbors/parents for each case. In our experiments, the neighbors chosen by KNN were not
always similar to those chosen by BPatch.
There are some extensions of KNN that have addressed some of the limitations of KNN (see the survey
for such techniques [Bhatia and Vandana, 2010]). As explained in [Bhatia and Vandana, 2010], most of these
extensions are improvements over basic kNN to gain speed efficiency as well as space efficiency and may hold
good in particular field under particular circumstances. Since we cannot compare our model with all of the
extensions of KNN, we chose two of the most relevant extensions of KNN and compare our results with them.
The first extension is the KNN with distance weighted votes, where the training points are assigned weights
according to their distances from sample data point (we used the inverse of the distance). The second extension
is KNN with feature weights. We chose K in KNN and Sα in our models to be the same, so that, on average,
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the same number of features are selected for each neighbor. The results of this comparison are shown in Fig. 14.
The performance of our model was still better than KNN and its two extensions. In KNN and its extensions,
whether or not distance weights, feature weights, or bandwidths are considered, the comparison between a
new case and a case in the training set is always based on a fixed formula with a fixed number of neighbors.
Our distance metric is more flexible.
K (in KNN) or αS (in our models) 
2 4 6 8 10
A
cc
ur
ac
y 
(%
)
66
68
70
72
74
76
78
80
82
b) Breast Cancer Data Set
Model 1
Model 2
KNN
KNN with inverse weights
KNN with feature weights
K (in KNN) or αS (in our models) 
2 4 6 8 10
A
cc
ur
ac
y 
(%
)
74
76
78
80
82
84
86
a) Heart Disease Data Set#
Model 1
Model 2
KNN
KNN with inverse weights
KNN with feature weights
Fig. 14: Comparison between our model, KNN, and its two extensions.
3.4.3 Comparison with BCM
To adapt the Bayesian Case Model Kim et al. [2014] for supervised classification (and health outcome predic-
tion), the mixture vector pi from BCM can be used as a feature of length S for input to other classification
methods, such as SVM and logistic regression. In Fig. 15, we compared our models (Model I and Model II)
with four possible values for S ∈ {20, 40, 60, 80, 100} and compared it with 6 cases of BCM (combinations of
S = 4, S = 8, S = 12, and α = 0.01 and α = .1). Note that no larger S was considered for BCM simply due to
the low performance of the trained models. The performance of BPatch was generally better.
Interpreting BPatch’s results may also be easier than interpreting those of BCM. The posterior estimate of
the mixture vector pi over the prototypes is not directly interpretable since the prototypes are not fixed, but we
can make choices that allow for sparser or larger mixtures. Let us consider BCM under two conditions for the
hyperparameter α used in Kim et al. [2014], which controls the sparsity of the prototypes chosen for a new case.
Sparse BCM (e.g., α = 0.01): Only one prototype generates each observation. Table 6 shows this prototype,
which shares some of the feature values with the new observation.
Non-sparse BCM (e.g., α = 1): BCM chooses multiple prototypes, however, only one prototype generates each
feature of the new patient. In contrast, BPatch’s features are generated from multiple parents. Table 6 illustrates
this.
3.4.4 Comparison with Decision Trees
Decision trees are a completely different form of interpretable model that is not case-based. In the datasets we
are considering, there are many good predictive models (a large “Rashomon Set”) meaning that many models
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TABLE 6: A sample patient, predicted prototypes in BCM (sparse & non-sparse) vs. parents in our model (Model
II)
Model
Feature F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13
Similarity
Index
True
Health
Sample Patient 2 1 3 2 3 1 1 3 2 2 2 1 2 2
BCM
α=.01
1st Prototype 3 2 3 3 1 2 2 3 1 2 2 2 2 1 2
BCM
α=1
1st Prototype 2 1 2 2 3 2 1 3 1 1 1 1 1 0.15 1
2nd Prototype 3 2 3 3 3 1 1 3 2 2 2 2 2 0.54 2
3rd Prototype 1 2 3 2 1 1 1 3 1 1 1 1 1 0.00 1
4th Prototype 1 2 3 1 1 1 1 3 2 2 2 1 2 0.31 2
Model II
1st Parent 2 1 3 2 3 1 1 3 2 2 2 1 2 1 2
2nd Parent 3 1 3 3 3 1 2 3 2 2 2 1 2 0.11 2
3rd Parent 3 1 3 3 3 1 2 3 2 2 2 1 1 0.08 2
4th Parent 2 1 2 3 1 1 2 3 2 2 2 1 1 0.05 1
that are different from each other that all perform well. We used CART, whose performance (shown in Table 5)
was not as strong as some of the other methods. Interestingly, the features that CART identifies were not the
same as those identified by BPatch. The feature ranking from both methods is shown in Fig. 16. More result is
given in Appendix D.
3.5 Application to Larger Dataset and its Computational Challenges
Computation is the major challenge for BPatch. Here, we show that BPatch’s performance does not deteriorate
on a slightly larger dataset with more samples and more features, despite more challenging computation.
This dataset is provided by the Center for Clinical and Translational Research, Virginia Commonwealth
University and is also available at the UCI website [Strack et al., 2014]. This data has been prepared to analyze
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Fig. 16: Feature ranking comparison between BPatch and decision trees (left: heart disease data set, right: breast
cancer data set.
factors related to readmission as well as other outcomes pertaining to patients with diabetes. The dataset
represents 10 years (1999-2008) of clinical care at 130 US hospitals and integrated delivery networks. Similar to
Strack et al. [2014], we focused on early readmission, and defined the readmission label (i.e., health outcome)
as having two values: “readmitted,” if the patient was readmitted within 30 days of discharge or “otherwise,”
which covers both readmission after 30 days and no readmission at all. The list of the features and their possible
outcomes are given in Table 7, where features age and time-in hospital were discretized. We used data from
two sets of 500 patients each, performed 5-fold cross-validation, and reported the average accuracy for BPatch
and similar methods in Table 8. The hyperparameters are the same as previous experiments and the number of
parents was set to 60. Again, most methods give comparable results, with BPatch’s accuracy somewhere in the
middle. For interpretability, we also checked (not shown here) that selected neighbors were reasonably close to
their respective patients.
TABLE 7: The attributes used in this paper for the readmission dataset
feature Name Description feature Name Description
Race
Caucasian, AfricanAmerican,
others
Final diagnosis
Diabetes, circulatory system,
respiratory system, digestive system,
Injury and poisoning, Other
Gender male, female Metformin Up, Down
Age [10(i-1)–10i], i ∈ {1..9} Glimepiride Up, Down
discharge disposition id Discharged to home, otherwise Glipizide Up, Down
Admission source
emergency room, physician/clinic
referral, otherwise
Glyburide Up, Down
Time in hospital <2,2-7, >7 Pioglitazone Up, Down
Medical specialty
InternalMedicine, Family/General
Practice, Cardiology, others
Rosiglitazone Up, Down
A1Cresult >7, >8, none, other Insulin Up, Down
DiabetesMed Yes, No Admission type Emergency, Other
Changes in diabetes Yes, no
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TABLE 8: Results for comparison between our model and benchmark models in the readmission data sets
Learning Type Accuracy Sensitivity Specificity Precision Recall F-measure
Model (I) - (S=60) 74.50 84.97 64.05 70.58 84.97 79.26
Our Model (II)- (S=60) 75.4 82.7 68.0 72.6 82.7 79.1
BCM (S = 4, α = 1) 76.80 85.99 67.73 72.73 85.99 78.74
BCM (S = 8, α = 1) 77.30 87.40 67.30 72.79 87.40 79.36
Logistic Regression 75.9 78.5 73.2 74.5 78.5 76.4
KNN (30) 62.3 96.1 28.7 57.5 96.1 71.8
KNN (20) 63.1 96.5 29.8 58.0 96.5 72.4
KNN (10) 64.1 95.4 32.9 59.0 95.4 72.7
KNN (5) 67.3 92.7 42.3 61.8 92.7 73.9
KNN (1) 66.9 88.0 45.9 62.0 88.0 72.6
Random Forest (5) 78.8 83.2 74.4 76.7 83.2 79.6
Random Forest (10) 80.6 84.6 76.5 78.5 84.6 81.4
Random Forest (100) 83.1 85.7 80.5 81.7 85.7 83.6
Decision Tree 77.9 78.9 76.9 77.5 78.9 78.1
SVM 67.0 88.2 45.6 65.6 88.2 73.6
boosted DT (100, I) 79.3 82.4 75.9 77.9 82.4 80.0
boosted DT (50, I) 78.7 83.0 74.2 76.7 83.0 79.6
boosted DT (10, I) 75.0 82.6 67.5 72.3 82.6 76.7
boosted DT (5, I) 72.4 84.7 60.0 68.5 84.7 75.3
boosted DT ( 100, II) 74.3 79.7 68.7 72.1 79.7 75.5
boosted DT (50, II) 74.3 79.7 68.7 72.1 79.7 75.5
boosted DT (10, II) 74.3 79.7 68.7 72.1 79.7 75.5
boosted DT (5, II) 74.3 79.7 68.7 72.1 79.7 75.5
As shown in Fig. 17 for all three data sets, as the number of parents increases, it takes more time to learn
the structure of the model. It is also shown that training Model I is faster than Model II. Also, given the same
number of parents and prototypes, each step of BPatch and BCM takes around the same amount of time, but
BPatch uses more memory, mainly due to the existence of 3-dimensional variable w. Thus, we can conclude
that without sacrificing accuracy, our model is slightly slower than BCM and much slower than the rest of the
models presented in Table 5. On the other hand, there is something to be gained from that extra computation,
and the tradeoff between computation and the need for interpretability should depend on the application.
BPatch is currently suited for smaller datasets (e.g., clinical trials, data from rare diseases, preliminary studies
with high-quality hand-curated samples, data from one physician’s case files, or data from one department in a
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hospital) where one requires a high level of interpretability in order to reason about cases.
4 CONCLUSION AND FUTURE WORK
Doctors reason through cases already. In a sense, we are proposing a data-driven formalization of techniques
that are used in an ad hoc way throughout much of current practice. In some sense, one could view Bayesian
Patchworks as a form of adaptive k nearest neighbors. Each case is generated by several neighbors, each
using a different distance measure to the present case. In the generative sense, each patient is built the way a
patchwork quilt is built; the larger design is built from pieces gathered from other sources. It is easy to argue
that considering neighbors through different lenses (as Bayesian Patchworks does) makes more sense than
fixing one distance measure, and having only one way to search for nearest neighbors.
Bayesian Patchworks operates similarly to real estate “comps,” which are similar properties previously
sold that one might use to price a current house on the market. There are many possible future extensions of
Bayesian Patchworks, for instance, one could modify the prior to favor using fewer total parents. Or, one could
generalize the method to handle problems other than classification. Regression would be a trivial extension, but
more complex outputs could be more interesting.
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APPENDIX A
APPENDIX: INFERENCE
The model hyperparameters are denoted as ϑ = {α, γ, σ1, σ2, λ0, λ, µ0, µ}. Given a set of known (X,Y) and
hyperparameters ϑ, the full posterior, which is the product of the likelihood and priors, can be computed as
Pr(q, q˜, z,w,φ, θ|X,Y,ϑ) ∝ Pr(X,Y|q, q˜, z,w,φ, θ,ϑ)× Pr(q, q˜, z,w,φ, θ|ϑ) (5)
= Pr(Y|θ,ϑ)× Pr(X|φ,ϑ)
× Pr(φ|w, z,ϑ) × Pr(θ|z,ϑ)× Pr(z|ϑ) × Pr(w|q˜,ϑ)× Pr(q˜|q,ϑ)× Pr(q,ϑ).
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We can use conjugate priors to simplify the above expression and also integrate out the latent factorsφ, θ, and, q˜.
This simplifies to:
∫ ∫ ∫
Pr(q, q˜, z,w,φ, θ|X,Y,ϑ) dq˜ dθ dφ (6)
∝
∫
Pr(w|q˜,ϑ) Pr(q˜|q,ϑ) dq˜ (= Pr(w|q,ϑ))
×
∫
Pr(X|φ,ϑ) Pr(φ|w, z,ϑ)dφ (= Pr(X|z,w,ϑ))
×
∫
Pr(Y|θ,ϑ) Pr(θ|z,ϑ)dθ (= Pr(Y|z,ϑ))
× Pr(q|ϑ) × Pr(z|ϑ)
= Pr(w|q,ϑ) × Pr(X|z,w,ϑ) × Pr(Y|z, ϑ) × Pr(q|ϑ) × Pr(z|ϑ).
The rest of the calculations will be for the three integrations inside Eq. (6) (lines 2-4). After performing these
integrations, we will be left only with q, z, and w. The details of those calculations are given in Appendix A.
From the results given in Appendix A, we have the following three important relationships, which can be used
to compute Pr(w|q,ϑ), Pr(X|z,w,ϑ), and Pr(Y|z, ϑ) in Eq. (6), respectively:
Pr(w:bj |qj) =
∫ 1
0
(Pr(w:bj |q˜bj)) Pr(q˜bj |qj) dq˜bj (7)
=
B(q′j +
∑
i
1{wibj = 1}, σ2 +N −
∑
i
1{wibj = 1})
B(q′j , σ2)
,
Pr(xij |wi:j , zi:) =
∫
Pr(xij |φij) Pr(φij |wi:j , zi:)dφij =
gij(xij) + 1∑
v
gij(v) + 1
. (8)
Pr(yi|zi:) =
∫
Pr(yi|θi) Pr(θi|zi:)dθi =
hi(yi) + 1∑
m
hi(m) + 1
. (9)
where q′j = σ2qj/(1− qj) and B(a, b) is the Beta function with parameters a and b.
A.1 Metropolis-within-Gibbs (MWG)
An iteration of MCMC cycles over the components of the parameter vectors q, z, and w, keeping everything
else fixed. We first show that the conditional posterior distributions ofw, z, and q admit closed forms. Denoting
q−j as the set of all parameters in the model except for qj (including the w’s and z’s, and implicitly including
the variables that have been integrated out already), we have
Pr(qj |q
−
j ) ∝ Pr(qj)×
∏
b
Pr(w:bj |qj) (10)
= Pr(qj)×
∏
b
B(q′j +
∑
i
1{wibj = 1}, σ2 +N −
∑
i
1{wibj = 1})
B(q′j , σ2)
,
where
∏
i
Pr(wibj |qj) is obtained from Eq. (7). The step above uses conditional independence with respect to
the qj ’s, and other conditional independences specified in the model. It should be noted that given a node’s
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parents in a directed acyclic graph, that node is conditionally independent of its grandparents and any other
ancestors (see Proposition 5.2 in Jackman [2009] on how to find conditional distribution using directed acyclic
graph). Now we have a simple form for the conditionals that drive the MCMC sampler. We use a Metropolitan
Hastings algorithm to sample from the above conditional distribution.
The rest of the parameters (z andw) in the model can be sampled directly from the conditional distributions
using Gibbs sampling. In particular, using
∏
i
Pr(wibj |qj) from Eq. (7) and Pr(xij |wi:j , zi:) from Eq. (8), we get
the following:
Pr(wibj = k|w
−
ibj) ∝ Pr(wibj = k|qj)× Pr(xij |wi:j , zi:, wibj = k) (11)
∝
B(q′j +
∑
i′
1{wi′bj = 1}, σ2 +N −
∑
i′
1{wi′bj = 1})
B(q′j , σ2)
×
gij(xij) + 1∑
v
gij(v) + 1
, (given wibj = k),
where w−ibj includes all variables exceptwibj . This means that we can sample directly from the above conditional
distribution as k takes only two possible values of 0 and 1.
Finally, using that the xij ’s and yi’s are the children of zib, we get
Pr(zib = k|z
−
ib) ∝ Pr(zib = k)×
∏
j
Pr(xij |wi:j , zi:)× Pr(yi|zi:), (12)
which can be simplified using Eqs. (8) and (9) to
Pr(zib = k|z
−
ib) ∝


(1− α)
∏
j
gij(xij)+1∑
v
gij(v)+1
hi(yi)+1∑
m
hi(m)+1
, (given zib = 0) if k = 0;
α
∏
j
gij(xij)+1∑
v
gij(v)+1
hi(yi)+1∑
m
hi(m)+1
, (given zib = 1) if k = 1.
(13)
Now, we can implement a Metropolis within-Gibbs sampling method to generate samples of the posterior
distribution. After we draw samples for z = {zib} (Eq. 13), q = {qj} (Eq. 10), andw = {wibj} (Eq. 11), we then
calculate the posterior predictive distribution for all measures of interest. At iteration t, we sample
1) z(t) from Pr(zib|z
−
ib
(t)) using direct sampling,
2) q(t) from Pr(qj |q
−
j
(t)) using random-walk Metropolis-Hastings, and
3) w(t) from Pr(wibj |w
−
ibj
(t)) using direct sampling.
For better identifiably, we can add a constraint for w so that if zib = 0, then all wibj become zero for all j.
However, since this changes the structure of the directed acyclic graph and adds more steps to calculate the
conditional distributions for z and w, we chose not to do that in this paper.
A.2 Inference for outcomes
Let us assume that Ψ = {z,w, q} is the set of parameters that can be learned from dataset (X,Y), which
includes N + S past cases which do not include patient r. Similarly, let Ψr denote the parameters associated
only with the rth individual (i.e.,Ψr = {zr:, wr::}). We can write the posterior predictive distribution as:
Pr(yr = m|xr,X,Y) =
∫
(Ψ,Ψr)
Pr(yr = m|Ψ,Ψr) Pr(Ψr,Ψ|X,Y,xr) d(Ψ,Ψr). (14)
Then according to the model, Pr(Ψr,Ψ|X,Y,xr) is the posterior distribution given xr,X, and Y (which can
be calculated from Eq. (6)). The term Pr(yr = m|Ψ,Ψr) can be calculated given that yr follows a Categorical
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distribution with parameter vector hi, which can be directly calculated from Ψr (i.e. Pr(yr = m|Ψ,Ψr) =
hi(m)).
Now, if (Ψ
(k)
r ,Ψ(k)) is the output of the MCMC at the kth iteration, k = {1,··· ,K} (see Section A.1), the
posterior predictive distribution can be estimated using
Pr(yr = m|xr,X,Y) (15)
≈
1
K
∑
k
Pr(yr = m|Ψ
(k)
r ,Ψr
(k)) Pr(Ψ(k)r ,Ψ
(k)|X,Y,xr).
For Type III predictions, we simply input (X,Y,xr, yr) in to the model in the learning process and then use
the posterior predictive distribution in Eq. (15) to carry out inference for the parameters of interest.
APPENDIX A
SIMPLIFICATION OF THE POSTERIOR DISTRIBUTION
After performing the integrations discussed above, we will be left only with q, z, and w. For the first term, we
have ∫
Pr(w|q˜,ϑ) Pr(q˜|q,ϑ) dq˜ =
∫ 1
0
∏
b
∏
j
Pr(w:bj |q˜bj) Pr(q˜bj |qj) dq˜bj (16)
=
∏
b
∏
j
∫ 1
0
(Pr(w:bj |q˜bj)) Pr(q˜bj |qj) dq˜bj
= Pr(w|q,ϑ).
As stated earlier, Pr(wibj |q˜bj) has a Bernoulli distribution with parameter q˜bj and Pr(q˜bj |qj) is a Beta
distribution with parameters (σ2 qj/(1 − qj), σ2). Since the posterior predictive distribution of a Binomial
random variable with a Beta distribution prior on the success probability is a Beta-Binomial distribution, the
inner integral in Eq. (16) becomes
∏
i
Pr(wibj |qj) =
∫ 1
0
(
∏
i
Pr(wibj |q˜bj)) Pr(q˜bj |qj) dq˜bj (17)
=
B(q′j +
∑
i
1{wibj = 1}, σ2 +N −
∑
i
1{wibj = 1})
B(q′j , σ2)
,
where q′j = σ2qj/(1− qj) and B(a, b) is the Beta function with parameters a and b. We can now use Eq. (17) in
Eq. (16) to find Pr(w|q,ϑ). At this point, the full posterior calculation no longer involves q˜. Thus,
Pr(w|q,ϑ) =
∏
b
∏
j
(
Pr(w:bj |qj)
)
.
By the conjugate property of the Beta distribution, we know that
Pr(q˜bj |w:bj , qj) ∼ Beta(q
′
j +
∑
i
1{wibj=1}, N −
∑
i
1{wibj=1} + σ2). (18)
From the mean of the Beta distribution given in Eq. (18), we can conclude that given qj and vector
[w1bj , · · · , wNbj ],
E(q˜bj) =
q′j +
∑
i
1{wibj=1}
q′j + σ2 +N
.
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For the second term of Eq. (6), we have
∫
Pr(X|φ) Pr(φ|w, z)dφ =
∫ ∏
i
∏
j
Pr(xij |φij) Pr(φij |wi:j , zi:)dφij (19)
=
∏
i
∏
j
∫
Pr(xij |φij) Pr(φij |wi:j , zi:)dφij
= Pr(X|z,w,ϑ).
We know that Pr(φij |wi:j , zi:) is a Dirichlet distribution, Dir(gij), and Pr(xij |φij) is a Categorical distribution,
Cat(φij). Since the posterior predictive distribution of a Categorical distribution with a Dirichlet distribution
prior on the probability vector is a Dirichlet-Categorical distribution, thus the inner integral of Eq. (19) becomes
Pr(xij |wi:j , zi:) =
∫
Pr(xij |φij) Pr(φij |wi:j , zi:)dφij =
gij(xij) + 1∑
v
gij(v) + 1
. (20)
We can now use Eq. (20) in Eq. (19) to find Pr(X|z,w,ϑ). At this point, the calculation of the full posterior no
longer involves φ. Since the Dirichlet distribution is the conjugate prior of the Categorical distribution, we have
Pr(φij |xij , wi:j , zi:) ∼ Dir(gij(:) + δ1), (21)
where δ1(v) = 1{xij=v}. We can conclude from Eq. (21) that given xij , vector [wi1j ,··· , wiSj ], and vector
[zi1,··· , ziS ], we can estimate E(φij(v)) as follows:
E(φij(v)) =
gij(xij) + 1{xij=v}∑
v
gij(v) + 1
.
For the third term in Eq. (6), we have
∫
Pr(Y|θ) Pr(θ|z)dθ =
∫ ∏
i
Pr(yi|θi) Pr(θi|zi:)dθ (22)
=
∏
i
∫
Pr(yi|θi) Pr(θi|zi:)dθi
= Pr(Y|z, ϑ).
We know that Pr(θi|zi) follows a Dirichlet distribution, Dir(hi), and Pr(yi|θi) follows a Categorical distribu-
tion, Cat(θi). Since the posterior predictive distribution of a Categorical distribution with a Dirichlet distribution
prior on the probability vector is a Dirichlet-Categorical distribution, the inner integral in Eq. (22) becomes
Pr(yi|zi:) =
∫
Pr(yi|θi) Pr(θi|zi:)dθi =
hi(yi) + 1∑
m
hi(m) + 1
. (23)
We can now use Eq. (23) in Eq. (22) to find Pr(X|z,w,ϑ). At this point, the calculation of the full posterior no
longer involves θ.
Since the Dirichlet distribution is the conjugate prior of Categorical distribution, we have
Pr(θi|yi, zi:) ∼ Dir(hi(:) + δ2), (24)
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where δ2(m) = 1{yi=v}, ∀m ∈ {1,··· ,M}. We can conclude from Eq. (24) that given yi and vector [zi1,··· , ziS ],
we can estimate E(θi(m)) as
E(θi(m)) =
hi(yi) + 1{m = yi}∑
m
hi(m) + 1
.
Now that the latent factors φ, θ, and, q˜ are integrated out, we can use a sampling process for estimating the rest
of the parameters.
APPENDIX B
POSTERIOR FOR MODEL II
The posterior becomes
Pr(q, q˜, z,w,φ, θ|X,Y,ϑ) ∝ Pr(X,Y|q, q˜, z,w,φ, θ,ϑ)× Pr(q, q˜, z,w,φ, θ|ϑ) =
Pr(Y|θ,w)× Pr(X|φ) × Pr(φ|w, z) × Pr(θ|w, z)× Pr(w|q˜)× Pr(q˜|q)× Pr(q)× Pr(z). (25)
The conditional distribution for q remains the same as the model described in Section 2.1, however for z and
w, the conditional distributions become
Pr(zib = k|z
−
ib) ∝ Pr(zib = k)×
∏
j
Pr(xij |wibj , zib)× Pr(yi|wi::, zib), (26)
= αk(1− α)(1−k)
∏
j
gnewij (xij) + 1∑
v
gnewij (v) + 1
hnewi (yi) + 1∑
m
hnewi (m) + 1
,
Pr(wibj = k|w
−
ibj) (27)
∝ Pr(wibj = k|qj)× Pr(xij |wi:j , zi:, wibj = k)× Pr(yi|wi:j , zi:, wibj = k)
=
B(q′j +
∑
i
1{wibj = 1}, σ2 +N −
∑
i
1{wibj = 1}
B(q′j , σ2)
)×
gnewij (k) + 1∑
v
gnewij (v) + 1
×
hnewi (yi) + 1∑
m
hnewi (m) + 1
.
APPENDIX C
MODEL III
In this model, the relationship between parent b and individual i can have a degree/weight between 0 and 1
following a Beta distribution. This is different from both Models I and II where zib is a binary variable. Based
on this relationship, if i and b are neighbors (i.e., zib=1), then κib ∈ (0, 1) reflects the degree of connection. On
the other hand, if i and b are not neighbors, then κib = 0. It is assumed that any nonzero κib follows a Beta
distribution with hyperparameters (τ, σ3). Note that the influences of neighbors on the generation of feature
values and health labels are the same as Eqs. (3), and (4), respectively. All other parameters of the model are
the same as in Model I. The directed acyclic graph of this model is given in Fig. 18. Based on this model, the
model hyperparameters are denoted as ϑ = {α, γ, σ1, σ2, λ0, λ, µ0, µ, a, b}. Given a set of known (X,Y) and
hyperparameters ϑ, the full posterior can be computed as:
Pr(q, q˜,κ, z,w,φ, θ|X,Y,ϑ) ∝ Pr(X,Y|q, q˜,κ, z,w,φ, θ,ϑ)× Pr(q, q˜,κ, z,w,φ, θ|ϑ) =
Pr(Y|θ)× Pr(X|φ)× Pr(φ|w,κ) × Pr(θ|κ)× Pr(w|q˜)× Pr(κ|z) × Pr(q˜|q)× Pr(q)× Pr(z). (28)
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Fig. 18: Directed acyclic graph for Model III. Circles indicate stochastic nodes; squares indicate fixed nodes
(hyperparameters); directed edges (arrows) indicate parent-child relations.
By repeating the same steps as we did in Section 2.1 to omit (q˜, θ,φ), we get∫ ∫ ∫
Pr(q, q˜,κ, z,w,φ, θ|X,Y,ϑ) dq˜ dθ dφ (29)
= Pr(w|q) Pr(X|κ,w) Pr(Y|κ) Pr(κ|z) Pr(z) Pr(q).
In the sampling process, q and w are generated the same as the original model, except that g and h are
calculated according to Eq. (3) and Eq. (4). The conditional distribution of κib and zib are as follows:
Pr(κib|κ
−
ib) ∝ Pr(κib|zib)×
∏
j
Pr(xij |wi:j , κi:)× Pr(yi|κi:). (30)
Given the relationship between κ and z, we get
Pr(κib = κ|κ
−
ib) ∝


Beta(k; τ, σ3)×
∏
j
gnewij (xij)+1∑
v
gnewij (v)+1
hnewi (yi)+1∑
m
hnewi (m)+1
if zib = 1 and κ ∈ [0, 1];
1 if zib = 0 and κ = 0
0 if zib = 0 and κ 6= 0.
(31)
For the elements of z, we have
Pr(zib = k|z
−
ib) ∝ Pr(zib = k)× Pr(κij |zib), (32)
which gives
Pr(zib = k|z
−
ib) ∝


0 if κib 6= 0, k = 0,
1 if κib 6= 0, k = 1
(1 − α) if κib = 0, k = 0
α if κib = 0, k = 1
. (33)
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APPENDIX D
MORE COMPARISON WITH DECISION TREE
To further evaluate the results given in Fig. 16, we evaluate our models under the following 5 cases, (i) all
features with equal weights, (ii) features with weights estimated from each model, (iii) the top three features,
(iv) the top six features, and (v) the top nine features. To have a fuller comparison, a different method, here
KNN, is used for classification. Results (in terms of accuracy) given in Fig. 19 verifies that weights and feature
ranking from our model are comparable to the ones from the decision tree in both data sets.
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Fig. 19: Comparison between the feature importance and ranking provided by our model and decision tree
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